OpenLegislation

Part 4 Outer and immediate packaging: advanced therapy medicinal products ...F1F2

  1. 34Paragraph 34
  2. 35Paragraph 35
  3. 36Paragraph 36
  4. 37Paragraph 37
  5. 38Paragraph 38
  6. 39Paragraph 39
  7. 40Paragraph 40
  8. 41Paragraph 41
  9. 42Paragraph 42
  10. 43Paragraph 43
  11. 44Paragraph 44
  12. 45Paragraph 45
  13. 46Paragraph 46
  14. 47Paragraph 47
  15. 48Paragraph 48
  16. 49Paragraph 49
  17. 50Paragraph 50

Annotations

Textual amendments

F1

Sch. 24 Pts. 4, 5 inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 201(5) (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 155(d)); 2020 c. 1, Sch. 5 para. 1(1)

F2

Words in Sch. 24 Pt. 4 heading omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 142(g)